GHK-CU
This Tripeptide has been shown to enhance elasticity, reduce inflammation, and protect against oxidative damage. These three major areas have shown a reduction in wrinkles and inflammation, an increase in skin firmness, and an overall more even tone.
GHK-CU OVERVIEW
Category: Naturally occurring Tripeptide, Copper Chelate, Regenerative agent
How It Works: Acts as a "copper chaperone" and signalling agent, modulating the expression of over 4,000 human genes that have been linked to repair and antioxidant defense.
Chemical Structure: Gly-His-Lys (complexed with Cu2)
Alternative Names: Copper Peptide
CAS Number: 49557-75-7
WHAT IS GHK-CU
Short for its literal chemical structure (Glycyl-L-histidyl-L-lysine-copper), GHK-Cu is a naturally occurring tripeptide inside the human body. Originally discovered in the 1970s by Dr. Loren Pickart during studies on liver regeneration and wound healing. Thanks to its high affinity for copper ions it has been praised for its regenerative, antioxidant, and anti-inflammatory properties.
WHAT DOES GHK-CU DO?
GHK-Cu's activity within the body is multi-functional, with the natural peptides production declining from approximately 200 ng/mL at age 20 to approximately 80 ng/mL by age 60. This decline in levels is thought to correlate with the decrease in regenerative function we see in humans.
By replacing the peptide's natural production with a topical version, numerous key benefits have been observed.
- Gene Modulation: one of its most striking benefits. It has been observed to regulate approximately 4,000 human genes, essentially shifting the gene expression of aged cells to resemble that of younger, healthier cells.
- Collegan & Elastin Boost: acts as a major regulator of ECM production. Synthesizing collagen 1 and 3, elastin, and glycosaminoglycans. Providing the skin with a major wrinkle reduction.
- Antioxidant Protection: Neutralizes free radicals inside the body, providing an environmental stress defense.
- Brightening Effect: regulates melanocyte activity, resulting in a decrease in hyperpigmentation.
- Barrier Repair: Improves the epidermal strength, allowing the skin to maintain moisture retention.
- Wound Healing: stimulates growth factors and angiogenesis, improving post-procedure recovery and healing from chronic wounds.
BENEFITS/ CLINICAL TRIALS
GHK-Cu is extensively studied, particularly in dermatology and regenerative medicine. Many studies have supported its topical application benefits.
Benefits include:
- Skin Anti-Aging
- Reduced fine lines and wrinkles
- Increased density and firmness
- Wound Healing:
- Accelerated closure
- Reduced Scarring
- Hair Growth
- Tissue Repair
Clinical Trials:
While most clinical trials often focus on a topical application, they have provided strong evidence for benefits.
- Topical application in women with photodamaged skin showed a significant reduction in lines and wrinkles as well as improved skin thickness compared to the placebo and Vitamin K cream after 12 weeks of application.
- Studies also confirmed procollegagen synthesis to be increased by almost 70% in dermal fibroblasts.
SIDE EFFECTS
GHK-Cu is characterized by a high safety profile and is generally well-tolerated. However, it is also important to understand possible side effects.
- Mild irritation: redness, dryness, or itching at the application site.
- Temporary shedding: Much like other growth agents, users have reported brief periods of skin shedding as follicles cycle into new growth phases.
- Copper toxicity: the biggest concern is shown in an accumulation of Copper in the bloodstream, particularly with individuals who have preexisting diseases such as Wilson's disease.
- Theoretical Proliferation Risk: As with all growth factor peptides, due to its promotion of cell growth, it raises a theoretical potential to increase the potency of malignancies. Although some research it may actually possess anti-cancer properties.
IS GHK-CU SAFE?
Thanks to its natural production in the body, the body is already very used to the presence of GHK-Cu. Pre-clinical trials have shown favorable toxicity results, and it is considered to be safe by most researchers.
GHK-Cu is not approved by the FDA for systemic therapeutic use (injection) as a drug. While its topical safety record is strong, its systemic safety and efficacy for treating medical conditions have not been established through comprehensive, large-scale, independent Phase 3 human trials.
DOSAGE
Topical use is the most clinically proven method. Systemic dosing is based on research models.
-
Administration (Topical): Most common; incorporated into creams or serums at concentrations typically below 1%.
-
Administration (Systemic): Subcutaneous (SubQ) injection in research settings.
-
Dosing Range (Systemic): Research protocols typically use very low doses, often in the microgram (mcg) range, or low single-digit milligrams (mg) per day, reflecting its high biological potency as a signaling molecule.
-
Cycle Length: Systemic protocols vary widely and may involve short cycles (30 days on and 14 days off).
RECONSTITUTION
A 10 mg vial of lyophilized GHK-Cu powder, the standard recommendation is to use 1.0 mL of bacteriostatic water. This creates a final concentration of 10 mg/mL, which is easy to dose accurately with an insulin syringe.
After reconstitution, store in a refrigerator between 2C to 8C for 14-28 days.
Step by step guidelinesWHERE TO BUY RETATRUTIDE
Researchers should always vet their sources to ensure that a few key factors are present in their test subjects. With the rise in peptide popularity in recent years, many companies have created peptides that undergo little to no testing, quality standards, or regulations. As it is not regulated by the FDA, researchers must do their due diligence and look closely at the company's practices and standards.
When selecting a supplier for GHK-Cu, focus on transparency and quality assurance, not customer testimonials:
- Quality Documentation: A reputable supplier must provide:
- Certificate of Analysis (COA): This document must be recent (corresponding to the batch/lot number purchased) and demonstrate a minimum purity of >95% via High-Performance Liquid Chromatography (HPLC) testing.
- Mass Spectrometry (MS) Data: The COA must include mass spectrometry (MS) confirmation to verify the compound’s exact molecular weight, confirming its chemical identity.
- Contaminant Testing: Look for reports on heavy metals, microbial load, and solvent residues (e.g., residual trifluoroacetic acid, or TFA). The presence of these contaminants can severely compromise research and introduce unknown toxicity.
- Vendor Verification and Transparency
-
Specialization: Prioritize vendors who specialize in the manufacturing and distribution of peptides for academic and biotechnology research, rather than general supplement vendors.
-
Manufacturing Origin: Inquire about the source of the raw materials and the manufacturing protocols. Ideal suppliers adhere to strict quality control processes.
-
Handling & Storage: The supplier must provide clear documentation on the proper storage and handling procedures for the peptide to maintain its stability and integrity.
-
Conclusion on Procurement: Given the high risk of contamination, mislabeling, and legal ambiguity. The use of GHK-Cu outside of this defined research context poses unacceptable, unquantified risks to human health.
REFERENCES
- by, Written. “Unlocking the Secrets of GHK-Cu: The Revolutionary Peptide for Youthfu.” Swolverine, swolverine.com/blogs/blog/unlocking-the-secrets-of-ghk-cu-the-revolutionary-peptide-for-youthful-skin-and-healing. Accessed 12 Nov. 2025.
- L;, Pickart. “The Human Tri-Peptide GHK and Tissue Remodeling.” Journal of Biomaterials Science. Polymer Edition, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/18644225/. Accessed 12 Nov. 2025.
- Pickart, Loren, and Anna Margolina. “Skin Regenerative and Anti-Cancer Actions of Copper Peptides.” MDPI, Multidisciplinary Digital Publishing Institute, 21 Apr. 2018, www.mdpi.com/2079-9284/5/2/29.
- R;, Wasner G;Heckmann K;Maier C;Baron. “Vascular Abnormalities in Acute Reflex Sympathetic Dystrophy (CRPS I): Complete Inhibition of Sympathetic Nerve Activity with Recovery.” Archives of Neurology, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/10328258/. Accessed 12 Nov. 2025.
- Pickart, Loren, and Anna Margolina. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” International Journal of Molecular Sciences, U.S. National Library of Medicine, 7 July 2018, pmc.ncbi.nlm.nih.gov/articles/PMC6073405/.
- by, Written. “GHK-Cu Peptide for Hair Growth: Science, Benefits, and How It Works.” Swolverine, swolverine.com/blogs/blog/ghk-cu-peptide-for-hair-growth-science-benefits-and-how-it-works?_pos=2&_sid=e89a95047&_ss=r. Accessed 12 Nov. 2025.
- GHK-Cu Dosing Guide, 45330025.fs1.hubspotusercontent-na1.net/hubfs/45330025/Alpa%20Bio%20Med%20Dosing%20Guides/GHK-Cu%20Dosing%20-%20Updated%20072825.pdf. Accessed 13 Nov. 2025.
- “How to Reconstitute Peptides: JPT.” JPT Peptide Technologies, www.jpt.com/blog/reconstitute-peptides/#:~:text=Dissolving%20the%20Peptide,lead%20to%20aggregation%20or%20degradation. Accessed 12 Nov. 2025.
-
BioMed Research International. "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration."
-
MDPI (ID 1422-0067/19/7/1987). "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data."
-
PMC (ID PMC8789089). "The potential of GHK as an anti-aging peptide."
-
BioImpacts. "Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective."
-
Wound Repair and Regeneration. "Thymosin beta 4 enhances dermal wound healing by regulating key cellular processes."
-
Dr.Oracle. "What are the benefits and risks of using $\text{GHK-Cu}$ ($\text{Glycyl-Histidyl-Lysine-Copper}$) peptide for wound healing and tissue repair?"
The PrepTide: Disclaimer